Adam Camblin

Adam Camblin is an accomplished professional in the field of biotechnology with extensive experience in non-clinical development and research. Currently serving as Associate Director of Non-Clinical Development at Beam Therapeutics since June 2020, Adam has held various roles, including Senior Scientist and Scientist II. Prior to this, Adam worked at Morphic Therapeutic as a Scientist and at Merrimack in multiple capacities, including Senior Associate Scientist and Research Associate. Adam's career began with internships at notable institutions such as Joslin Diabetes Center and Blood Centers of the Pacific. Adam holds a Doctor of Philosophy (PhD) in Molecular Biology, Cellular Biology, and Biochemistry and a Bachelor's degree in Biochemistry and Molecular Biology, both from Boston University, and a French Baccalaureate from French American International High School.